The existing National Action Plan on Acceleration of Malaria Elimination in Indonesia (NAP-AMEI) for 2020-2024 was no longer feasible given the circumstances of the malaria programme after the COVID-19 pandemic. Out of the three specific targets set in the NAP-AMEI, only one was achieved.

The Ministry of Health (MOH) had just endorsed the NAP-AMEI 2020-2024 document in February 2020 when the COVID-19 pandemic was declared by WHO. This led to significant disruptions in malaria services, such as a reduction of over 30% in malaria case detection, delays in distributing long-lasting insecticidal nets (LLINs), and stockouts of malaria drugs due to companies reducing the medicine production and transportation delays. These factors contributed to the failure in achieving most of the NAP-AMEI targets.